Roberta Cannella
34Patents
6h-index
19Co-inventors
62Inventor score
Filing activity: Jul 21, 2005 → Dec 16, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8426450B1 | Substituted 4-phenyl pyridines having anti-emetic effect | Chemistry; Metallurgy | 13 | Active |
| US7947724B2 | Liquid pharmaceutical formulations of palonosetron | Performing Operations; Transporting | 13 | Expired |
| US7947725B2 | Liquid pharmaceutical formulations of palonosetron | Performing Operations; Transporting | 12 | Expired |
| US7960424B2 | Liquid pharmaceutical formulations of palonosetron | Performing Operations; Transporting | 12 | Expired |
| US8518981B2 | Liquid pharmaceutical formulations of palonosetron | Performing Operations; Transporting | 10 | Active |
| USD665072S1 | Capsule for pharmaceutical products | General | 10 | Active |
| US8598219B2 | Liquid pharmaceutical formulations of palonosetron | Performing Operations; Transporting | 6 | Active |
| US8598218B2 | Liquid pharmaceutical formulations of palonosetron | Performing Operations; Transporting | 6 | Active |
| US8729094B2 | Liquid pharmaceutical formulations of palonosetron | Performing Operations; Transporting | 5 | Active |
| US9186357B2 | Compositions and methods for treating centrally mediated nausea and vomiting | Human Necessities | 4 | Active |
| US9403772B2 | 4-(5-(2-(3,5-bis(trifluoromethyl)phenyl)-N,2-dimethylpropanamido)-4-(o-tolyl)pyridin-2-yl)-1-methyl-1-((phosphonooxy)methyl)piperazin-1-ium as a neurokinin receptor modulator | Chemistry; Metallurgy | 4 | Active |
| US9066980B2 | Liquid pharmaceutical formulations of palonosetron | Performing Operations; Transporting | 3 | Active |
| US8623826B2 | Compositions and methods for treating centrally mediated nausea and vomiting | Human Necessities | 3 | Active |
| US9125905B2 | Liquid pharmaceutical formulations of palonosetron | Performing Operations; Transporting | 2 | Active |
| US9173942B2 | Liquid pharmaceutical formulations of palonosetron | Performing Operations; Transporting | 2 | Active |
| US8951969B2 | Compositions and methods for treating centrally mediated nausea and vomiting | Human Necessities | 1 | Active |
| US10624911B2 | Physiologically balanced injectable formulations of fosnetupitant | Human Necessities | 1 | Active |
| US9308266B2 | Liquid pharmaceutical formulations of palonosetron | Performing Operations; Transporting | 1 | Active |
| US11559523B2 | Compositions and methods for treating centrally mediated nausea and vomiting | Human Necessities | 0 | Active |
| US11529362B2 | Physiologically balanced injectable formulations of fosnetupitant | Human Necessities | 0 | Active |
| US12042494B2 | Compositions and methods for treating centrally mediated nausea and vomiting | Human Necessities | 0 | Active |
| US10828297B2 | Compositions and methods for treating centrally mediated nausea and vomiting | Human Necessities | 0 | Active |
| US8895586B2 | Methods of treating emesis | Chemistry; Metallurgy | 0 | Active |
| US9457021B1 | Liquid pharmaceutical formulations of palonosetron | Performing Operations; Transporting | 0 | Active |
| US9908907B2 | Substituted piperaziniums for the treatment of emesis | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.